| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |